```json
{
"content": [
{
"type": "paragraph",
"content": "The Fetal and Neonatal Heart Monitor market encompasses medical devices and technologies designed to assess cardiac health in unborn babies and newborns. These tools are critical for early detection of congenital heart defects, ensuring timely interventions in maternal and pediatric care. The Fetal and Neonatal Heart Monitor market size is projected to reach USD 580 million by 2026, reflecting a robust growth outlook across the 2026–2033 forecast period. This industry expansion is supported by rising prevalence of cardiovascular disorders in neonates, advancements in non-invasive monitoring technologies, and increased adoption of point-of-care diagnostics. The market is expected to grow at a CAGR of ~12.5%, driven by macro-level factors including healthcare digitization, regulatory incentives for maternal-fetal health programs, and rising healthcare expenditures in emerging economies."
},
{
"type": "chart",
"chartType": "segment-stacked",
"data": {
"segments": ["Fetal Monitoring", "Neonatal Monitoring"],
"periods": ["2021", "2022", "2023", "2024", "2025", "2026", "2027", "2028", "2029", "2030", "2031", "2032", "2033"],
"values": [
[320, 340, 365, 390, 415, 440, 470, 500, 530, 560, 590, 620, 650], // Fetal
[180, 190, 205, 220, 235, 240, 250, 265, 280, 295, 310, 325, 340] // Neonatal
]
}
},
{
"type": "paragraph",
"content": "Key forces shaping the Fetal and Neonatal Heart Monitor market include technological innovation, such as AI-driven anomaly detection and wearable biosensors, and regulatory tailwinds favoring real-time monitoring solutions. North America currently holds the largest market share, fueled by advanced healthcare infrastructure and high adoption rates of cutting-edge devices. Meanwhile, Asia-Pacific is the fastest-growing region, driven by expanding healthcare access, rising awareness campaigns, and a growing middle-class population seeking quality maternal-neonatal care. Strategic collaborations between OEMs and digital health platforms, coupled with reimbursement reforms, are anticipated to further accelerate market forecast growth through 2033."
}
]
}
```
